Rusan Pharma LTD Walk-in Interview 2021 B Pharma / M Pharma for Regulatory Affairs At Gandhidham, Kandla. Rusan Pharma LTD Notification full details below.Interested and eligible candidates can Send Your resume..
- Vacancy details:
- Post Name: Regulatory Affairs
- Qualification: B Pharma / M Pharma
- Experience: 3 to 8 years
Job Description: Rusan Pharma LTD Hiring For Regulatory Affairs !
- Important Details :
- Location: Gandhidham, Kandla
- Note:Interested Candidates Kindly Mail your updated CV on firstname.lastname@example.org
- Contact: Priti Singhvi-022-42383063
- Post of date:22/12/2021
- Selection Process: The selection will be on the basis of Interview.
- Walk-in Interview Regulatory Affairs , Rusan Pharma LTD
Job Responsibilities –
There is an opening for “Regulatory Affairs” with RUSAN PHARMA LTD (R&D center) at Gandhidham Location.
Working with Operations for Publishing of the Dossier (Independently Module 1- 5) as per country requirements (eCTD/CTD/National Requirements).
Chair of Labelling Sub team Meetings (LST) which includes Subject Matter Experts from Medical Affairs, Pharmacovigilance, Clinical Development and Nonclinical Development.
Maintain awareness of changes to/new regulations affecting Pharmacovigilance activities.
Knowledge of Preparation & compilation and reviewing the documents which is coming from manufacturing site for the preparation of dossiers for various countries along with legal documentations.
Tender file Preparation, as per the bid documents.
Regulatory activities include pre licensing activities, new registration of products, post licensing regulatory submissions, interaction with health authorities of respective countries.
Rusan is a research driven pharmaceutical company having its Manufacturing Units in India and Worldwide Marketing of Pharmaceutical Formulation, Active Pharmaceutical Ingredients and Intermediates. The company has its own Research & Development centre at Kandivli (west), Mumbai, state of the art, Bulk Manufacturing Plant at Ankleshwar and Formulation plant at Dehradun and SEZ, Kandla having approval of MHRA (UK), MCC (SA) and other International Health Authorities. March 2008 – 82 Crs., Expected by March 2009 €“ 150 Crs.